Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Huang

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
The Lancet. Infectious Diseases|May 28, 2005
Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infectionDavid B Huang, Herbert L DuPont
Diagnostic Microbiology and Infectious Disease|February 22, 2020
Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017David B Huang, Cedric Charrier, Stephen Hawser
Seminars in Pediatric Infectious Diseases|October 21, 2004
Cryptosporidiosis in childrenDavid B Huang, Cynthia Chappell, Pablo C Okhuysen
The American Journal on Addictions|December 22, 2006
Demographic characteristics and antisocial personality disorder of early and late onset alcoholics identified in a primary care clinicDavid B Huang, Paresh P Kamat, Jay Wang
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Access Microbiology|September 25, 2020
Evaluation of <i>in vitro</i> activity of iclaprim in combination with other antimicrobials against pulmonary pathogens: a pilot studyDavid B Huang, Cyntia de Piano, Sophie Magnet
BMC Infectious Diseases|April 1, 2014
Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniaeLeung-Kei Kristopher Siu, David B Huang, Tom Chiang
Journal of Global Antimicrobial Resistance|January 8, 2019
In vitro activity of dihydrofolate reductase inhibitors and other antibiotics against Gram-positive pathogens collected globally between 2004 and 2016Stephanie Noviello, Stephen Hawser, Helio Sader, et al.
Clinical Therapeutics|February 15, 2011
Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus pneumoniaeM Marian Ijzerman, Kenneth J Tack, David B Huang
Southern Medical Journal|December 14, 2004
Toxic epidermal necrolysis as a complication of treatment with voriconazoleDavid B Huang, Jashin J Wu, Christopher J Lahart
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
The Lancet. Infectious Diseases|May 28, 2005
Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infectionDavid B Huang, Herbert L DuPont
Diagnostic Microbiology and Infectious Disease|February 22, 2020
Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017David B Huang, Cedric Charrier, Stephen Hawser
Seminars in Pediatric Infectious Diseases|October 21, 2004
Cryptosporidiosis in childrenDavid B Huang, Cynthia Chappell, Pablo C Okhuysen
The American Journal on Addictions|December 22, 2006
Demographic characteristics and antisocial personality disorder of early and late onset alcoholics identified in a primary care clinicDavid B Huang, Paresh P Kamat, Jay Wang
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Access Microbiology|September 25, 2020
Evaluation of <i>in vitro</i> activity of iclaprim in combination with other antimicrobials against pulmonary pathogens: a pilot studyDavid B Huang, Cyntia de Piano, Sophie Magnet
BMC Infectious Diseases|April 1, 2014
Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniaeLeung-Kei Kristopher Siu, David B Huang, Tom Chiang
Journal of Global Antimicrobial Resistance|January 8, 2019
In vitro activity of dihydrofolate reductase inhibitors and other antibiotics against Gram-positive pathogens collected globally between 2004 and 2016Stephanie Noviello, Stephen Hawser, Helio Sader, et al.
Clinical Therapeutics|February 15, 2011
Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus pneumoniaeM Marian Ijzerman, Kenneth J Tack, David B Huang
Southern Medical Journal|December 14, 2004
Toxic epidermal necrolysis as a complication of treatment with voriconazoleDavid B Huang, Jashin J Wu, Christopher J Lahart
Pageof 9